Remedent to Present FirstFit, a Revolutionary Solution for Dental Bridges & Crowns, at the Den-Mat Education Destination Seminar in Las Vegas, Nevada, November 6-8, 2009
DEURLE, BELGIUM and LOS ANGELES, CA--(Marketwire - November 4, 2009) - Remedent, Inc. (OTCBB: REMI) an international company specializing in the research, development,
and manufacturing of oral care and cosmetic dentistry products, has been
invited to present FirstFit™, a patent-pending system for the creation
and placement of dental bridges and crowns, at Den-Mat Holding LLC's
Education Destination Seminar being held at the Hard Rock Hotel & Casino in
Las Vegas, Nevada on November 6-8, 2009.
The seminar is part of a conference for Minimally Invasive and Digital
Dentistry being hosted by the American Society for Clinical Research and
the Academy of General Dentistry. More than 500 dentists from across the
country and around the world are expected to attend the conference. Den-Mat
is the world's largest producer of dental veneers and the leading sponsor
of the conference.
The FirstFit presentation will be conducted by Remedent's CEO, Guy De
Vreese, on Saturday, November 7, with the Belgian inventor of FirstFit, Dr.
Evelyne Jacquemyns, presenting live via Web cast from one of Remedent's
international GlamSmile locations in Dubai, UAE. The event represents the
first official presentation of the new bridge and crown technology to
dentists in the United States since FirstFit's international introduction
in June of this year.
The FirstFit system requires no temporary placements, creates less mouth
trauma and takes fewer office visits to complete. With economic benefits
for both patients and dentists, the new technology addresses an expanding
U.S. market for dental crowns and bridges, and has the potential to change
the way modern dentistry is practiced.
"This presentation of FirstFit builds upon the success of our dental veneer
technology which Den-Mat markets as LUMITRAY®," said Guy De Vreese, CEO
of Remedent. "We expect the rollout of FirstFit, with Den-Mat's assistance,
will significantly expand our presence in the North American professional
dental market. We greatly value Den-Mat's substantial commitment of
resources to FirstFit as we introduce the many revolutionary features and
benefits the new technology offers both dentists and the consumer."
The three day event will also feature demonstrations of the LUMITRAY veneer
placement system that creates attractive, confident, life-changing smiles
without full-prep. LUMITRAY is also the only veneer placement system that
makes possible the placing of a full arch in one motion.
More information about the event is available on the American Society for
Clinical Research Web site at www.ascredu.org/three-day-seminars.html.
About Den-Mat Holdings, LLC
California-based Den-Mat Holdings, LLC is a leading manufacturer and
marketer of advanced cosmetic and restorative dental products and
laboratory services that allow a dentist to preserve, restore and enhance
their patient's teeth typically without the requirement for anesthesia,
extensive cutting, drilling and tooth removal. This revolutionary type of
dentistry not only focuses on superior aesthetic results, but on patient
comfort and convenience as well. Den-Mat's revolutionary LUMINEERS® BY
CERINATE® are porcelain veneers that offer a painless way to a
permanently whiter and perfectly aligned smile. LUMINEERS are the only
porcelain laminates that are strong, reversible, and have a proven record
of over 20 years of clinical success. The dentist applies these contact
lens-thin veneers to teeth without the need for the shaving and grinding
down of sensitive tooth structure that is common with traditional veneers.
Den-Mat is a unit of DLJ Merchant Banking Partners, a private equity
investment affiliate of Credit Suisse. For additional information, visit
www.denmat.com.
About Credit Suisse
As one of the world's leading banks, Credit Suisse provides its clients
with investment banking, private banking and asset management services
worldwide. Credit Suisse offers advisory services, comprehensive solutions
and innovative products to companies, institutional clients and high-net
worth private clients globally, as well as retail clients in Switzerland.
Credit Suisse is active in over 50 countries and employs approximately
40,000 people. Credit Suisse's parent company, Credit Suisse Group, is a
leading global financial services company headquartered in Zurich. Credit
Suisse Group's registered shares (CSGN) are listed in Switzerland and, in
the form of American Depositary Shares (CS), in New York. Further
information about Credit Suisse can be found at www.creditsuisse.com.
About Remedent
Remedent, Inc. specializes in the research, development, manufacturing and
marketing of oral care and cosmetic dentistry products. The company serves
the professional dental industry with breakthrough technology for dental
veneers, bridges and crowns which are recognized worldwide for their
technological superiority and ease-of-application. These products are
supported by a line of professional veneer whitening and teeth sensitivity
solutions. Headquartered in Belgium, Remedent distributes its products to
more than 35 countries worldwide. For more information, go to
www.rememdent.com.
Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release that are "forward-looking statements" are
based on current expectations and assumptions that are subject to risks and
uncertainties. Such forward-looking statements involve known and unknown
risks, uncertainties and other unknown factors that could cause the
company's actual operating results to be materially different from any
historical results or from any future results expressed or implied by such
forward-looking statements. In addition to statements that explicitly
describe these risks and uncertainties, readers are urged to consider
statements that contain terms such as "believes," "belief," "expects,"
"expect," "intends," "intend," "anticipate," "anticipates," "plans,"
"plan," "projects," "project," to be uncertain and forward-looking. Actual
results could differ materially because of factors because of such risks
and uncertainties. The agreement with Den-Mat for FirstFit is subject to
satisfaction or waiver of certain closing conditions which includes, in
addition to customary closing conditions, due diligence completed to
Den-Mat's satisfaction with respect to the FirstFit products; delivery of
legal opinion and certain executed non-competition agreements; and delivery
of the development payment and first installment of the license payment.
For further information regarding risks and uncertainties associated with
company's business, please refer to the risk factors described in the
Company's filings with the Securities and Exchange Commission, including,
but not limited to, its annual report on Form 10-K and quarterly reports on
Form 10-Q.
Contact Information: Company Contacts:
Stephen Ross
Chief Financial Officer
Remedent, Inc.
Tel (310) 922-5685
Investor Relations:
Ron Both
Managing Director
Liolios Group, Inc.
Tel (949) 574-3860